BMG LABTECH Customer Success Stories

Hear what our customers have to say about their experience with BMG LABTECH microplate readers.

Amount of items: 51

Tackling rare and neglected cancers with advanced screening

Charlotte Walsh-Tripp from Cancer Research Horizons discusses their approach to cancer research, focusing on challenging targets and utilizing advanced screening technologies.

Pioneering Pre-Clinical Drug Discovery with Advanced Assays

Discover how Excellerate Bioscience leverages advanced assays and PHERAstar technology to revolutionize pre-clinical drug discovery and pharmacology services.

CLARIOstar and PHERAstar support a variety of biological assays in early drug discovery with flexibility and precision

Nick Bland’s benefits: Z´ of 0.9 in HTS studies and the flexibility to run different assays.

Studying bacterial pathogens on BMG LABTECH readers

Andrew Roe professor at the University of Glasgow discusses molecular studies in bacteria and highlights BMG LABTECH´s reliability.

Building a bridge between organoid research and drug discovery

Elad Katz founder of Navigate Precision Biology established a 384-well based organoid platform and runs his assays with the PHERAstar.

The benefits of studying opioid, cannabinoid, terpenoid, and 5HT receptor agonists

Dr Marina Junqueira Santiago discusses the potential benefits of studying opioid, cannabinoid, terpenoid, and 5HT receptor agonists.

Targeted protein degradation – next-generation therapeutics

Helen Harrison, Director of Screening at Amphista Therapeutics, discusses targeted protein degradation and the discovery of drugs in this area.

Taking a wholistic approach to automation

Mathew Keegan talks about the seamless integration of BMG LABTECH plate readers into Automata´s system

Improving nucleic acid biomarker detection with DNA nanotechnology

Roma is co-founder of a start-up that uses the CLARIOstar Plus for the detection and quantification nucleic acids.

Searching for optimized drugs: combining AI with human expertise

Dr Martin Redhead (Head of Quantitative Pharmacology, Exscientia, UK)

missing

Malaria research on the CLARIOstar Plus

Thorey Jonsdottir (phD student, Malaria Virulence & Drug Discovery Group, Burnet Institute, AU)

missing

Streamlined and more efficient drug screening with the PHERAstar FSX

Dr Zaida Gloria (Principal Scientist, CALIBR Scripps Research, USA)

missing

Customer voices

High performance, reliability and excellent customer support are of the utmost importance to BMG LABTECH

Hear what our customers have to say about their experience with BMG LABTECH microplate readers

Hear what our customers have to say about their experience with BMG LABTECH microplate readers.

Tackling rare and neglected cancers with advanced screening

Pioneering Pre-Clinical Drug Discovery with Advanced Assays

CLARIOstar and PHERAstar support a variety of biological assays in early drug discovery with flexibility and precision

Studying bacterial pathogens on BMG LABTECH readers

Building a bridge between organoid research and drug discovery

The benefits of studying opioid, cannabinoid, terpenoid, and 5HT receptor agonists

Targeted protein degradation – next-generation therapeutics

Taking a wholistic approach to automation

Improving nucleic acid biomarker detection with DNA nanotechnology

Searching for optimized drugs: combining AI with human expertise

Malaria research on the CLARIOstar Plus

Streamlined and more efficient drug screening with the PHERAstar FSX